Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2023-02-23 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房控股股东、实际控制人、董事和高级管理人员关于向不特定对象发行可转换公司债券摊薄即期回报采取填补措施的承诺（修订稿）的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company Yifeng Pharmacy Chain Co., Ltd. regarding commitments made by controlling shareholders, actual controllers, directors, and senior management about measures to compensate for dilution of immediate returns caused by the issuance of convertible bonds to unspecified objects. It includes formal commitments and legal responsibility statements. The document is relatively short (1536 characters) and does not contain financial statements or detailed financial data. It is a regulatory announcement related to compliance with capital market regulations and shareholder protections, rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance and commitment announcement without substantive financial data or report content.
2023-02-23 Chinese
益丰药房关于变更经营范围及修订《公司章程》的公告
Board/Management Information Classification · 95% confidence The document is a company announcement regarding changes to the business scope and amendments to the company's articles of association (公司章程). It details the board meeting resolution approving these changes and the need for shareholder approval. The document does not contain financial statements, audit information, or detailed financial data. It is not a report itself but an announcement of corporate governance changes related to business scope and company bylaws. This fits best under Board/Management Information (MANG) as it involves board resolutions and governance changes, but not detailed governance practices (which would be CGR). The document length is short (2616 characters), and it is not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2023-02-23 Chinese
关于向不特定对象发行可转换公司债券系列文件修订情况说明的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from the board of directors of 益丰大药房连锁股份有限公司 regarding revisions to a series of documents related to the issuance of convertible bonds to unspecified investors. It details board meetings, shareholder meetings, and specific amendments to the bond issuance plan and related documents. The text is an official public announcement describing changes to financing plans and regulatory compliance, but it does not contain actual financial statements or detailed financial results. The document length is 3860 characters, which is relatively short and consistent with an announcement rather than a full report. The content focuses on capital raising activities and bond issuance adjustments, which aligns with a Capital/Financing Update. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2023-02-23 Chinese
益丰药房关于签署募集资金专户存储四方监管协议的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Yifeng Pharmacy Chain Co., Ltd. regarding the signing of a four-party supervision agreement for the special account storage of raised funds. It details the background of the convertible bonds issuance, the opening of special accounts for the raised funds, and the supervisory responsibilities of involved parties including the sponsor and the bank. The document is a formal announcement about the management and supervision of fundraising proceeds, not a financial report or audit. It does not contain financial statements or results but focuses on regulatory compliance and procedural details related to fundraising. The document length is 3391 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2023-02-15 Chinese
益丰药房关于归还暂时用于补充流动资金的可转换公司债券募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding the repayment of temporarily used convertible bond funds for working capital. It includes specific financial figures and references to previous announcements but does not contain a full financial report or detailed financial statements. The document is relatively short (802 characters) and focuses on capital usage and repayment updates. This fits the description of a Capital/Financing Update (CAP) rather than a full report or regulatory filing. Therefore, the appropriate classification is CAP.
2023-01-31 Chinese
益丰药房关于归还暂时用于补充流动资金的可转换公司债券募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company Yifeng Pharmacy Chain Co., Ltd. regarding the repayment of temporarily used convertible bond funds for supplementing working capital. It discusses the use and repayment of raised funds, referencing previous announcements and disclosing current repayment status. The content is about capital usage and financing activities, specifically related to convertible bonds and fund management. It is not a full financial report, audit, or earnings release, but an update on capital/financing activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is short and focused on financing updates, not a report publication or regulatory filing.
2022-12-30 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.